Literature DB >> 16816231

A validation of event-related FMRI comparisons between users of cocaine, nicotine, or cannabis and control subjects.

Kevin Murphy1, Veronica Dixon, Kathleen LaGrave, Jacqueline Kaufman, Robert Risinger, Alan Bloom, Hugh Garavan.   

Abstract

OBJECTIVE: Noninvasive brain imaging techniques are a powerful tool for researching the effects of drug abuse on brain activation measures. However, because many drugs have direct vascular effects, the validity of techniques that depend on blood flow measures as a reflection of neuronal activity may be called into question. This may be of particular concern in event-related functional magnetic resonance imaging (fMRI), where current analytic techniques search for a specific shape in the hemodynamic response to neuronal activity.
METHOD: To investigate possible alterations in task-related activation as a result of drug abuse, fMRI scans were conducted on subjects in four groups as they performed a simple event-related finger-tapping task: users of cocaine, nicotine, or cannabis and control subjects.
RESULTS: Activation measures, as determined by two different analytic methods, did not differ between the groups. A comparison between an intravenous saline and an intravenous cocaine condition in cocaine users found a similar null result. Further in-depth analyses of the shape of the hemodynamic responses in each group also showed no differences.
CONCLUSIONS: This study demonstrates that drug groups may be compared with control subjects using event-related fMRI without the need for any post hoc procedures to correct for possible drug-induced cardiovascular alterations. Thus, fMRI activation differences reported between these drug groups can be more confidently interpreted as reflecting neuronal differences.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16816231     DOI: 10.1176/ajp.2006.163.7.1245

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   19.242


  10 in total

1.  Neurobiological impact of nicotinic acetylcholine receptor agonists: an activation likelihood estimation meta-analysis of pharmacologic neuroimaging studies.

Authors:  Matthew T Sutherland; Kimberly L Ray; Michael C Riedel; Julio A Yanes; Elliot A Stein; Angela R Laird
Journal:  Biol Psychiatry       Date:  2015-01-07       Impact factor: 13.382

2.  Acute effects of cocaine on the neurobiology of cognitive control.

Authors:  Hugh Garavan; Jacqueline N Kaufman; Robert Hester
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

3.  Anatomical differences and network characteristics underlying smoking cue reactivity.

Authors:  Xiaochu Zhang; Betty Jo Salmeron; Thomas J Ross; Hong Gu; Xiujuan Geng; Yihong Yang; Elliot A Stein
Journal:  Neuroimage       Date:  2010-08-03       Impact factor: 6.556

4.  Altered cerebral blood flow and neurocognitive correlates in adolescent cannabis users.

Authors:  Joanna Jacobus; Diane Goldenberg; Christina E Wierenga; Neil J Tolentino; Thomas T Liu; Susan F Tapert
Journal:  Psychopharmacology (Berl)       Date:  2012-03-07       Impact factor: 4.530

5.  Association of nicotine addiction and nicotine's actions with separate cingulate cortex functional circuits.

Authors:  L Elliot Hong; Hong Gu; Yihong Yang; Thomas J Ross; Betty Jo Salmeron; Brittany Buchholz; Gunvant K Thaker; Elliot A Stein
Journal:  Arch Gen Psychiatry       Date:  2009-04

6.  Neural correlates of automatic and controlled auditory processing in schizophrenia.

Authors:  Rajendra A Morey; Teresa V Mitchell; Seniha Inan; Jeffrey A Lieberman; Aysenil Belger
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2008       Impact factor: 2.198

Review 7.  Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings.

Authors:  Albert Batalla; Sagnik Bhattacharyya; Murat Yücel; Paolo Fusar-Poli; Jose Alexandre Crippa; Santiago Nogué; Marta Torrens; Jesús Pujol; Magí Farré; Rocio Martin-Santos
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

Review 8.  The neuropsychopharmacology of cannabis: A review of human imaging studies.

Authors:  Michael A P Bloomfield; Chandni Hindocha; Sebastian F Green; Matthew B Wall; Rachel Lees; Katherine Petrilli; Harry Costello; M Olabisi Ogunbiyi; Matthijs G Bossong; Tom P Freeman
Journal:  Pharmacol Ther       Date:  2018-10-19       Impact factor: 12.310

9.  Delta-9-tetrahydrocannabinol reduces the performance in sensory delayed discrimination tasks. A pharmacological-fMRI study in healthy volunteers.

Authors:  Carmen Walter; Bruno G Oertel; Lisa Felden; Ulrike Nöth; Ralf Deichmann; Jörn Lötsch
Journal:  IBRO Rep       Date:  2019-11-13

10.  Cannabinoid modulation of functional connectivity within regions processing attentional salience.

Authors:  Sagnik Bhattacharyya; Irina Falkenberg; Rocio Martin-Santos; Zerrin Atakan; Jose A Crippa; Vincent Giampietro; Mick Brammer; Philip McGuire
Journal:  Neuropsychopharmacology       Date:  2014-09-23       Impact factor: 7.853

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.